| Tbio | Chromodomain-helicase-DNA-binding protein 7 |
Probable transcription regulator. Maybe involved in the in 45S precursor rRNA production.
This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Comments
| Disease | Target Count | P-value |
|---|---|---|
| pancreatic ductal adenocarcinoma liver metastasis | 1795 | 5.46149406388953E-4 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| CHARGE syndrome | 23 | 8.396 | 4.0 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Klinefelter's syndrome | 59 | 5.064 | 2.5 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Choanal atresia | 19 | 7.025 | 3.5 |
| Coloboma | 52 | 6.748 | 3.4 |
| Hypogonadism | 70 | 4.698 | 2.3 |
| Congenital heart disease | 63 | 4.369 | 2.2 |
| Esophageal atresia | 25 | 3.67 | 1.8 |
| Cryptorchidism | 67 | 3.554 | 1.8 |
| Tinea favosa | 3 | 3.469 | 1.7 |
| Osgood-Schlatter's disease | 6 | 3.258 | 1.6 |
| Lichen nitidus | 3 | 3.165 | 1.6 |
| DiGeorge syndrome | 46 | 3.141 | 1.6 |
| Intellectual disability | 573 | 3.064 | 1.5 |
| Disease | Target Count |
|---|---|
| Idiopathic scoliosis 3 | 1 |
| Disease | log2 FC | p |
|---|---|---|
| pancreatic ductal adenocarcinoma liver m... | 1.510 | 0.001 |
| Species | Source |
|---|---|
| Chimp | OMA EggNOG |
| Macaque | OMA EggNOG |
| Mouse | OMA EggNOG Inparanoid |
| Rat | OMA EggNOG Inparanoid |
| Dog | OMA EggNOG Inparanoid |
| Cow | OMA EggNOG Inparanoid |
| Pig | OMA EggNOG Inparanoid |
| Opossum | OMA EggNOG Inparanoid |
| Anole lizard | OMA Inparanoid |
| PMID | Text |
|---|---|
| 26590800 | Pathogenic CHD7 variants are associated with CHARGE syndrome. |
| 26551301 | Two mutations of CHD7 were identified including a novel splice-site mutation (c.2443-2A>G) and a previously known frameshift mutation (c.2504_2508delATCTT). |
| 26411921 | Here, we review recent work aimed at understanding the mechanism of CHD7 function in normal and pathological states, highlighting results from biochemical and in vivo studies. |
| 26334530 | CHARGE syndrome due to deletion of region upstream of CHD7 gene START codon. |
| 25472840 | Functionally compromised CHD7 missense alleles contribute to the pathogenesis of both the anosmic and normosmic forms of Isolated gonadotropin-releasing hormone deficiency. |
| 25257999 | CHD7 mutations are not a major cause of atrioventricular septal and conotruncal heart defects. |
| 25077900 | The objective of the study was to determine the nature, prevalence, mode of transmission, and clinical spectrum of CHD7 mutations in a large series of patients. |
| 24979395 | These data provide additional evidence that CHD7 mutations are a significant cause of semicircular canal atresia in children with full or partial CHARGE syndrome. |
| 24732674 | Mutations were found in the following genes in one or more patients with congenital hypogonadotropic hypogonadism: KAL1, FGFR1, GNRHR, and CHD7 |
| 24705355 | Like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5. We therefore propose that CHD7 and KMT2D function in the same chromatin modification machinery. |
| More... |
MADPGMMSLFGEDGNIFSEGLEGLGECGYPENPVNPMGQQMPIDQGFASLQPSLHHPSTNQNQTKLTHFD 1 - 70 HYNQYEQQKMHLMDQPNRMMSNTPGNGLASPHSQYHTPPVPQVPHGGSGGGQMGVYPGMQNERHGQSFVD 71 - 140 SSSMWGPRAVQVPDQIRAPYQQQQPQPQPPQPAPSGPPAQGHPQHMQQMGSYMARGDFSMQQHGQPQQRM 141 - 210 SQFSQGQEGLNQGNPFIATSGPGHLSHVPQQSPSMAPSLRHSVQQFHHHPSTALHGESVAHSPRFSPNPP 211 - 280 QQGAVRPQTLNFSSRSQTVPSPTINNSGQYSRYPYSNLNQGLVNNTGMNQNLGLTNNTPMNQSVPRYPNA 281 - 350 VGFPSNSGQGLMHQQPIHPSGSLNQMNTQTMHPSQPQGTYASPPPMSPMKAMSNPAGTPPPQVRPGSAGI 351 - 420 PMEVGSYPNMPHPQPSHQPPGAMGIGQRNMGPRNMQQSRPFIGMSSAPRELTGHMRPNGCPGVGLGDPQA 421 - 490 IQERLIPGQQHPGQQPSFQQLPTCPPLQPHPGLHHQSSPPHPHHQPWAQLHPSPQNTPQKVPVHQHSPSE 491 - 560 PFLEKPVPDMTQVSGPNAQLVKSDDYLPSIEQQPQQKKKKKKNNHIVAEDPSKGFGKDDFPGGVDNQELN 561 - 630 RNSLDGSQEEKKKKKRSKAKKDPKEPKEPKEKKEPKEPKTPKAPKIPKEPKEKKAKTATPKPKSSKKSSN 631 - 700 KKPDSEASALKKKVNKGKTEGSENSDLDKTPPPSPPPEEDEDPGVQKRRSSRQVKRKRYTEDLEFKISDE 701 - 770 EADDADAAGRDSPSNTSQSEQQESVDAEGPVVEKIMSSRSVKKQKESGEEVEIEEFYVKYKNFSYLHCQW 771 - 840 ASIEDLEKDKRIQQKIKRFKAKQGQNKFLSEIEDELFNPDYVEVDRIMDFARSTDDRGEPVTHYLVKWCS 841 - 910 LPYEDSTWERRQDIDQAKIEEFEKLMSREPETERVERPPADDWKKSESSREYKNNNKLREYQLEGVNWLL 911 - 980 FNWYNMRNCILADEMGLGKTIQSITFLYEIYLKGIHGPFLVIAPLSTIPNWEREFRTWTELNVVVYHGSQ 981 - 1050 ASRRTIQLYEMYFKDPQGRVIKGSYKFHAIITTFEMILTDCPELRNIPWRCVVIDEAHRLKNRNCKLLEG 1051 - 1120 LKMMDLEHKVLLTGTPLQNTVEELFSLLHFLEPSRFPSETTFMQEFGDLKTEEQVQKLQAILKPMMLRRL 1121 - 1190 KEDVEKNLAPKEETIIEVELTNIQKKYYRAILEKNFTFLSKGGGQANVPNLLNTMMELRKCCNHPYLING 1191 - 1260 AEEKILEEFKETHNAESPDFQLQAMIQAAGKLVLIDKLLPKLKAGGHRVLIFSQMVRCLDILEDYLIQRR 1261 - 1330 YPYERIDGRVRGNLRQAAIDRFSKPDSDRFVFLLCTRAGGLGINLTAADTCIIFDSDWNPQNDLQAQARC 1331 - 1400 HRIGQSKSVKIYRLITRNSYEREMFDKASLKLGLDKAVLQSMSGRENATNGVQQLSKKEIEDLLRKGAYG 1401 - 1470 ALMDEEDEGSKFCEEDIDQILLRRTHTITIESEGKGSTFAKASFVASGNRTDISLDDPNFWQKWAKKAEL 1471 - 1540 DIDALNGRNNLVIDTPRVRKQTRLYSAVKEDELMEFSDLESDSEEKPCAKPRRPQDKSQGYARSECFRVE 1541 - 1610 KNLLVYGWGRWTDILSHGRYKRQLTEQDVETICRTILVYCLNHYKGDENIKSFIWDLITPTADGQTRALV 1611 - 1680 NHSGLSAPVPRGRKGKKVKAQSTQPVVQDADWLASCNPDALFQEDSYKKHLKHHCNKVLLRVRMLYYLRQ 1681 - 1750 EVIGDQADKILEGADSSEADVWIPEPFHAEVPADWWDKEADKSLLIGVFKHGYEKYNSMRADPALCFLER 1751 - 1820 VGMPDAKAIAAEQRGTDMLADGGDGGEFDREDEDPEYKPTRTPFKDEIDEFANSPSEDKEESMEIHATGK 1821 - 1890 HSESNAELGQLYWPNTSTLTTRLRRLITAYQRSYKRQQMRQEALMKTDRRRRRPREEVRALEAEREAIIS 1891 - 1960 EKRQKWTRREEADFYRVVSTFGVIFDPVKQQFDWNQFRAFARLDKKSDESLEKYFSCFVAMCRRVCRMPV 1961 - 2030 KPDDEPPDLSSIIEPITEERASRTLYRIELLRKIREQVLHHPQLGERLKLCQPSLDLPEWWECGRHDRDL 2031 - 2100 LVGAAKHGVSRTDYHILNDPELSFLDAHKNFAQNRGAGNTSSLNPLAVGFVQTPPVISSAHIQDERVLEQ 2101 - 2170 AEGKVEEPENPAAKEKCEGKEEEEETDGSGKESKQECEAEASSVKNELKGVEVGADTGSKSISEKGSEED 2171 - 2240 EEEKLEDDDKSEESSQPEAGAVSRGKNFDEESNASMSTARDETRDGFYMEDGDPSVAQLLHERTFAFSFW 2241 - 2310 PKDRVMINRLDNICEAVLKGKWPVNRRQMFDFQGLIPGYTPTTVDSPLQKRSFAELSMVGQASISGSEDI 2311 - 2380 TTSPQLSKEDALNLSVPRQRRRRRRKIEIEAERAAKRRNLMEMVAQLRESQVVSENGQEKVVDLSKASRE 2381 - 2450 ATSSTSNFSSLSSKFILPNVSTPVSDAFKTQMELLQAGLSRTPTRHLLNGSLVDGEPPMKRRRGRRKNVE 2451 - 2520 GLDLLFMSHKRTSLSAEDAEVTKAFEEDIETPPTRNIPSPGQLDPDTRIPVINLEDGTRLVGEDAPKNKD 2521 - 2590 LVEWLKLHPTYTVDMPSYVPKNADVLFSSFQKPKQKRHRCRNPNKLDINTLTGEERVPVVNKRNGKKMGG 2591 - 2660 AMAPPMKDLPRWLEENPEFAVAPDWTDIVKQSGFVPESMFDRLLTGPVVRGEGASRRGRRPKSEIARAAA 2661 - 2730 AAAAVASTSGINPLLVNSLFAGMDLTSLQNLQNLQSLQLAGLMGFPPGLATAATAGGDAKNPAAVLPLML 2731 - 2800 PGMAGLPNVFGLGGLLNNPLSAATGNTTTASSQGEPEDSTSKGEEKGNENEDENKDSEKSTDAVSAADSA 2801 - 2870 NGSVGAATAPAGLPSNPLAFNPFLLSTMAPGLFYPSMFLPPGLGGLTLPGFPALAGLQNAVGSSEEKAAD 2871 - 2940 KAEGGPFKDGETLEGSDAEESLDKTAESSLLEDEIAQGEELDSLDGGDEIENNENDE 2941 - 2997 //
| PMID | Year | Title |
|---|---|---|
| 26590800 | 2016 | Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria. |
| 26551301 | 2016 | Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome. |
| 26411921 | 2015 | Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. |
| 26334530 | 2015 | CHARGE syndrome due to deletion of region upstream of CHD7 gene START codon. |
| 26187070 | 2015 | Identification of one novel CHD7 mutation in a patient from China with atypical CHARGE syndrome. |
| 25689927 | 2015 | CHARGE syndrome: a review of the immunological aspects. |
| 25553296 | 2015 | Non-homologous end joining repair mechanism-mediated deletion of CHD7 gene in a patient with typical CHARGE syndrome. |
| 25472840 | 2014 | Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency. |
| 25257999 | 2014 | CHD7 mutations are not a major cause of atrioventricular septal and conotruncal heart defects. |
| 25077900 | 2014 | The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. |
| More... |
